1
Sommadossi Jean Pierre, Gosselin Gilles, Pierra Claire, Perigaud Christian, Peyrottes Suzanne: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Centre National de La Recherche Scientifique, L Universite Montpellier Ii, Sommadossi Jean Pierre, Gosselin Gilles, Pierra Claire, Perigaud Christian, Peyrottes Suzanne, PATHAK Rahul, July 10, 2008: WO/2008/082601 (33 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


2
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, May 31, 2011: US07951789 (28 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


3
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, March 8, 2011: US07902202 (16 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


4
Dominique Surleraux, Gilles Gosselin: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Centre National de la Recherche Scientifique, Jones Day, March 25, 2014: US08680071 (12 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


5
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Centre National de la Recherche Scientifique, Universite Montpellier II, Jones Day, April 8, 2014: US08691788 (12 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


6
Dominique Surleraux, Cyril B Dousson, Christophe Claude Parsy: Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Squire Sanders, August 13, 2013: US08507460 (11 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral a ...


7
Dominique Surleraux, Cyril B Dousson, David Dukhan, Claire Pierra: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Jones Day, February 10, 2015: US08951985 (4 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


8
Dominique Surleraux, Gilles Gosselin: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Jones Day, January 26, 2016: US09243025 (2 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


9
SURLERAUX DOMINIQUE: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Rieger Dale L, October 6, 2011: WO/2011/123586 (2 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


10